Annual Drug Patent Expirations for AMRIX
Amrix is a drug marketed by Teva Pharms Intl and is included in one NDA. It is available from seven suppliers. There are eight patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for AMRIX.
This drug has one patent family member in one country.
The generic ingredient in AMRIX is cyclobenzaprine hydrochloride. Seven suppliers are listed for this compound. Additional details are available on the cyclobenzaprine hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
